Biomimetic Cascade‐Targeted Nanoplatform for Fluorescent Localization and Eradication of Oral Squamous Cell Carcinoma
Authors:
- 20 June 2025
- journal article
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (45)
Abstract
Nanodrug delivery systems hold tremendous promise for tumor therapy; however, challenges such as precise targeting, rapid drug release, and efficient drug utilization remain unresolved. Here, a biomimetic cascade‐targeted nanoplatform (graphene quantum dots‐RRL‐Evodiamine, GRE) that uniquely integrates both active and passive targeting strategies with a reactive oxygen species (ROS)‐responsive release mechanism is developed. The system employs RRL peptides for active recognition of overexpressed heat shock protein 70 (Hsp70) on oral squamous cell carcinoma (OSCC) membranes, mimicking natural ligand—receptor interactions; and thereby, imparting biomimetic targeting capability; while, Evodiamine (EVO) is covalently anchored to RRL‐modified graphene quantum dots (GQDs) through a ROS‐labile thioketal (TK) linker, ensuring precise and timely drug release. Moreover, the inherent fluorescence of GQDs enables real‐time tracking of drug delivery. Remarkably, GRE administration achieves 83% tumor volume reduction in vivo, outperforming free EVO (25%) by 3.3‐fold, underscoring the system's superior therapeutic efficacy. This multifunctional system establishes a paradigm for OSCC treatment by uniting biomimetic targeting, ROS‐triggered release, and integrated imaging into a single nanoplatform.Keywords
Funding Information
- National Natural Science Foundation of China (81970976)
This publication has 60 references indexed in Scilit:
- Recent Progress in Implantable Drug Delivery SystemsAdvanced Materials, 2024
- A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and ImmunoactivationAdvanced Materials, 2022
- Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast CancerAdvanced Materials, 2022
- HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cellsMolecular Carcinogenesis, 2021
- Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer ImmunotherapyAdvanced Materials, 2021
- ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer TherapyAdvanced Materials, 2017
- Germ cell‐specific heat shock protein 70‐2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cellsCancer, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9International Journal of Cancer, 2004
- Differential expression of 70–kDa heat shock‐protein in human oral tumorigenesisInternational Journal of Cancer, 1995